Seller record · Telehealth service

LunaRx

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 2 of 8 criteria. S3, pharmacy identification: The product pages say protocols are prepared by partner compounding pharmacies in the United States, and no pharmacy is named on the product pages, the peptide pages, the terms, the privacy policy or the contact page. 1 more criterion also fails; see the table below.

At a glance

LunaRxTelehealth service

6/8criteria passed
Price
Semaglutide from $146 a month, tirzepatide from $166
Sells
compounded semaglutide injection, compounded tirzepatide injection, and 8 more
FDA letters
None on file
Visit LunaRxSee all eight dispositions

Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.

An Austin telehealth service selling compounded semaglutide and tirzepatide, a GLP-1 microdose and an oral GLP-1, paired in stacks with a CJC-1295 and ipamorelin blend or NAD+, with compounded tesamorelin, sermorelin, NAD+ and PT-141. Care is offered in English and Spanish, and no filling pharmacy is named.

Operating entity LunaRx LLC

Dispositions

CodeCriterionDispositionWhere it appears
S1Prescriber requirementPASSLunaRx's semaglutide product page; LunaRx's peptides page
S2Prescription gatingPASSLunaRx's eligibility page; LunaRx's website
S3Pharmacy identificationFAILLunaRx's semaglutide product page; LunaRx's terms; LunaRx's contact page
S4Compounding disclosurePASSLunaRx's semaglutide product page; LunaRx's peptides page; LunaRx's tesamorelin product page
S5Analytical documentationFAILLunaRx's peptides page; LunaRx's terms; LunaRx's privacy page
S6Business addressPASSLunaRx's contact page; LunaRx's privacy page
S7Price disclosurePASSLunaRx's peptides page; LunaRx's website
S8Enforcement statusPASSFDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSAn independent, U.S.-licensed physician reviews and authorizes each consultation, and every order is evaluated and approved only if the treatment is right for the patient.Source: LunaRx's semaglutide product page; LunaRx's peptides page.
S2PASSThe check eligibility button opens an intake whose first screen asks what the buyer wants support with, and the home page says a buyer who is not approved is not charged.Source: LunaRx's eligibility page; LunaRx's website.
S3FAILThe product pages say protocols are prepared by partner compounding pharmacies in the United States, and no pharmacy is named on the product pages, the peptide pages, the terms, the privacy policy or the contact page.Source: LunaRx's semaglutide product page; LunaRx's terms; LunaRx's contact page.
S4PASSThe footer on every product page states that compounded medications are not FDA-approved and that their safety, efficacy and quality have not been verified by the FDA, and the peptide therapies page repeats it below the prices.Source: LunaRx's semaglutide product page; LunaRx's peptides page; LunaRx's tesamorelin product page.
S5FAILNo certificate of analysis or lot document is published on the product pages, the peptide pages, the terms or the privacy policy.Source: LunaRx's peptides page; LunaRx's terms; LunaRx's privacy page.
S6PASSLunaRx LLC at 5900 Balcones Drive, Suite 100, Austin, TX 78731, printed on the contact page and in the privacy policy.Source: LunaRx's contact page; LunaRx's privacy page.
S7PASSThe semaglutide injection from $146 a month, the tirzepatide injection from $166, the GLP-1 microdose and the oral GLP-1 from $199, tesamorelin from $270, sermorelin and PT-141 from $199 and NAD+ from $225, printed on the peptide therapies page. The home page prints the GLP-1 stacks from $146 a month in one place and from $199 a month in its banner, and says pricing is confirmed after the provider review.Source: LunaRx's peptides page; LunaRx's website.
S8PASSNo FDA warning letter names LunaRx or LunaRx LLC, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide injection, compounded tirzepatide injection, GLP-1 microdose, GLP-1 oral, CJC-1295/ipamorelin blend, compounded tesamorelin, sermorelin, NAD+, PT-141, high-volume B12.

Other sellers of the same products

Who sells semaglutideWho sells tirzepatideWho sells sermorelinWho sells NAD+Who sells PT-141Who sells tesamorelinWho sells ipamorelin

Visit LunaRx

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.